Clinical Trial Update: A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) [Phase 2, Phase 3]

View source ↗

Summary

A pediatric Phase 2/3 clinical trial evaluating Crinecerfont for congenital adrenal hyperplasia (classic CAH) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Congenital Adrenal Hyperplasia
• Congenital Adrenal Hyperplasia

Drugs mentioned

• Crinecerfont (crinecerfont)

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 2, Phase 3 | Status: RECRUITING